Transport of Multidrug Resistance Modulators in Tumor Cells
Author Information
Author(s): M. Sehested, T. Skovsgaard, P. Buhl Jensen, E.J.F. Demant, E. Friche, N. Bindslev
Primary Institution: Herlev University Hospital
Hypothesis
Do verapamil and azidopine have similar energy-dependent accumulation patterns in wild type and resistant tumor cells?
Conclusion
Both verapamil and azidopine do not follow the multidrug resistance efflux pathway to any significant extent in resistant cells.
Supporting Evidence
- Verapamil and azidopine accumulation was similar in both wild type and resistant cells.
- Azidopine increased daunorubicin accumulation in resistant cells.
- Both drugs did not appear to be transported by the multidrug resistance efflux mechanism.
Takeaway
The study looked at how two drugs, verapamil and azidopine, behave in cancer cells that are resistant to treatment. It found that these drugs don't get pushed out of the cells like other cancer drugs do.
Methodology
The study used cell lines to measure drug accumulation under different energy conditions and performed photolabeling and immunoprecipitation to analyze protein interactions.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo environments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website